ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

October 10, 2014

Funding Opportunities: DOD releases PA On Ovarian Cancer

August 6, 1999

Burton’s Clinic Reopens; Some Insurers Reportedly Reimbursing; New York Congressman Calls For Evaluation

March 28, 1986

Study Identifies Characteristics That Promote Early-Life NHL

May 25, 2012

CMS Develops New Math of Medicare: Reimbursement Money for Outcomes Data.

February 4, 2005

Larry Norton wins ASCO’s Karnofsky award.

May 28, 2004